Uscom Limited (ASX:UCM)
Australia · Delayed Price · Currency is AUD 0.0140
0.00 (0.00%)
Jul 11, 2025, 3:49 PM AEST
Uscom Revenue
Uscom had revenue of 1.86M AUD in the half year ending December 31, 2024, with 47.86% growth. This brings the company's revenue in the last twelve months to 3.63M, up 8.01% year-over-year. In the fiscal year ending June 30, 2024, Uscom had annual revenue of 3.73M with 39.89% growth.
Revenue (ttm)
3.63M
Revenue Growth
+8.01%
P/S Ratio
0.97
Revenue / Employee
103.74K
Employees
35
Market Cap
3.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 3.73M | 1.06M | 39.89% |
| Jun 30, 2023 | 2.66M | 154.48K | 6.16% |
| Jun 30, 2022 | 2.51M | -1.35M | -34.95% |
| Jun 30, 2021 | 3.86M | -426.65K | -9.96% |
| Jun 30, 2020 | 4.28M | 642.77K | 17.65% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |